Injecto A/S: Financial statements 2019
CVR: 38729888
Source: annual report 2019, Danish Business Authority
01/09/2018 – 31/08/2019
Injecto A/S (CVR 38729888) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -18,580 and a net result of DKK -30,802. Equity in the 2019 report amounted to DKK 2,148,218. The solvency ratio was 71.1%.
- Gross Profit
- DKK -18,580
- Profit/Loss
- DKK -30,802
- Equity
- DKK 2,148,218
- Total Assets
- DKK 3,020,988
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
On November 23, 2019, the company changed its name from Lubrigone A/S to Injecto A/S.
Injecto A/S has published its interim report for the period June 19, 2017 – August 31, 2018.
About Injecto A/S
Injecto A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Lubrigone A/S. The management consists of Torben Helmer Knudsen. The board consists of John Holger Adamsen (chair), Carsten Sylvester Larsen and Torben Helmer Knudsen. The company is owned by Injecto Group A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,590,948 and a net result of DKK -2,942,694 compared with DKK -2,982,525 the year before. Equity in the 2025 report amounted to DKK -43,454.
